Physician profile
Eric B Grossman
NPI 1659342202
$2,211.40
in general payments reported to CMS, 2019-2025
25 companies · $70.72 in 2025
The $70.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $137 · 2021: $329 · 2022: $303 · 2023: $796 · 2024: $285 · 2025: $70.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.22 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $256.63 | 2023-2025 | Myfembree |
| Abbvie INC. | $254.89 | 2019-2023 | |
| Astellas Pharma US INC | $245.52 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $213.51 | 2021-2024 | Acessa Provu System, Novasure, Coolseal Generator |
| Avion Pharmaceuticals | $172.44 | 2019-2022 | |
| Cytyc Surgical Products, LLC | $144.12 | 2023 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $96.26 | 2019-2023 | |
| Pfizer INC. | $91.70 | 2022-2023 | |
| Myovant Sciences INC. | $90.00 | 2021-2022 | |
| Evofem Biosciences, INC. | $87.88 | 2020-2024 | Phexxi |
| Amag Pharmaceuticals, INC. | $84.76 | 2019-2020 | |
| Organon LLC | $80.98 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $74.53 | 2019-2022 | |
| Coopersurgical, INC. | $45.49 | 2023-2024 | Endosee, Paragard T 380a |
| Agile Therapeutics, INC. | $40.96 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $37.14 | 2019-2020 | |
| Olympus America INC. | $35.73 | 2020-2023 | Gyrus Acmi, INC |
| Mylan Pharmaceuticals INC. | $29.96 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.38 | 2019-2021 | |
| Caldera Medical, INC | $24.10 | 2023 | Desara |
| Axonics, INC. | $22.54 | 2023 | Axonics |
| Sage Therapeutics, LLC | $15.25 | 2024 | |
| Channel Medsystems, INC. | $14.55 | 2022 | |
| Renovia INC | $13.48 | 2021 | |
| Minerva Surgical, INC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.